SEATTLE, March 15, 2023 /PRNewswire/ — OncoResponse, a clinical-stage biotech company advancing immunotherapies derived from the immune systems of Elite Cancer Responders, today announced a poster presentation at the upcoming American Association for Cancer Research Annual Meeting being…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.